Published in Science on February 02, 2001
Diversity of the human intestinal microbial flora. Science (2005) 49.64
The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci U S A (2004) 26.56
Interactions between the microbiota and the immune system. Science (2012) 10.45
Developmental regulation of intestinal angiogenesis by indigenous microbes via Paneth cells. Proc Natl Acad Sci U S A (2002) 9.78
Mucosa-associated bacteria in the human gastrointestinal tract are uniformly distributed along the colon and differ from the community recovered from feces. Appl Environ Microbiol (2002) 6.74
Enteric defensins are essential regulators of intestinal microbial ecology. Nat Immunol (2009) 6.10
Molecular monitoring of succession of bacterial communities in human neonates. Appl Environ Microbiol (2002) 5.76
Honor thy symbionts. Proc Natl Acad Sci U S A (2003) 5.72
Periodontitis: a polymicrobial disruption of host homeostasis. Nat Rev Microbiol (2010) 5.59
Immune adaptations that maintain homeostasis with the intestinal microbiota. Nat Rev Immunol (2010) 5.57
Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease. Gut (2004) 5.32
The gut microbiota--masters of host development and physiology. Nat Rev Microbiol (2013) 5.25
Gnotobiotic zebrafish reveal evolutionarily conserved responses to the gut microbiota. Proc Natl Acad Sci U S A (2004) 5.16
Microbes in gastrointestinal health and disease. Gastroenterology (2008) 4.65
Epidermal barrier formation and recovery in skin disorders. J Clin Invest (2006) 4.14
Toll-like receptor signalling in the intestinal epithelium: how bacterial recognition shapes intestinal function. Nat Rev Immunol (2010) 4.07
Soluble proteins produced by probiotic bacteria regulate intestinal epithelial cell survival and growth. Gastroenterology (2006) 3.96
16S rRNA gene-based analysis of fecal microbiota from preterm infants with and without necrotizing enterocolitis. ISME J (2009) 3.75
Bacteroides: the good, the bad, and the nitty-gritty. Clin Microbiol Rev (2007) 3.61
Microbial translocation augments the function of adoptively transferred self/tumor-specific CD8+ T cells via TLR4 signaling. J Clin Invest (2007) 3.54
Commensal Bacteroides species induce colitis in host-genotype-specific fashion in a mouse model of inflammatory bowel disease. Cell Host Microbe (2011) 3.46
Role of the microbiota in immunity and inflammation. Cell (2014) 3.43
Molecular diversity of Lactobacillus spp. and other lactic acid bacteria in the human intestine as determined by specific amplification of 16S ribosomal DNA. Appl Environ Microbiol (2002) 3.43
Epithelial antimicrobial defence of the skin and intestine. Nat Rev Immunol (2012) 3.21
The 'hygiene hypothesis' for autoimmune and allergic diseases: an update. Clin Exp Immunol (2010) 3.17
Microbiota restricts trafficking of bacteria to mesenteric lymph nodes by CX(3)CR1(hi) cells. Nature (2013) 2.95
Gut microbiome, obesity, and metabolic dysfunction. J Clin Invest (2011) 2.93
Staphylococcus epidermidis Esp inhibits Staphylococcus aureus biofilm formation and nasal colonization. Nature (2010) 2.85
The roles of bacteria and TLR4 in rat and murine models of necrotizing enterocolitis. J Immunol (2006) 2.83
Rapid quantitative profiling of complex microbial populations. Nucleic Acids Res (2006) 2.75
Live probiotics protect intestinal epithelial cells from the effects of infection with enteroinvasive Escherichia coli (EIEC). Gut (2003) 2.70
Gut commensal bacteria direct a protective immune response against Toxoplasma gondii. Cell Host Microbe (2009) 2.67
Analysis of gut microbial regulation of host gene expression along the length of the gut and regulation of gut microbial ecology through MyD88. Gut (2011) 2.67
The gut microbiota modulates host energy and lipid metabolism in mice. J Lipid Res (2009) 2.59
Probiotic bacterium prevents cytokine-induced apoptosis in intestinal epithelial cells. J Biol Chem (2002) 2.59
Double blind, placebo controlled trial of two probiotic strains in interleukin 10 knockout mice and mechanistic link with cytokine balance. Gut (2003) 2.37
The front line of enteric host defense against unwelcome intrusion of harmful microorganisms: mucins, antimicrobial peptides, and microbiota. Clin Microbiol Rev (2006) 2.36
Molecular features of adult mouse small intestinal epithelial progenitors. Proc Natl Acad Sci U S A (2003) 2.33
Diversity and succession of the intestinal bacterial community of the maturing broiler chicken. Appl Environ Microbiol (2003) 2.32
Reduction of disulphide bonds unmasks potent antimicrobial activity of human β-defensin 1. Nature (2011) 2.31
Sources of variability and effect of experimental approach on expression profiling data interpretation. BMC Bioinformatics (2002) 2.31
The human intestinal microbiome: a new frontier of human biology. DNA Res (2009) 2.30
The impact of perinatal immune development on mucosal homeostasis and chronic inflammation. Nat Rev Immunol (2011) 2.29
The Human Microbiome Project strategy for comprehensive sampling of the human microbiome and why it matters. FASEB J (2012) 2.13
Strain-resolved community genomic analysis of gut microbial colonization in a premature infant. Proc Natl Acad Sci U S A (2010) 2.09
Pathophysiological role of Toll-like receptor 5 engagement by bacterial flagellin in colonic inflammation. Proc Natl Acad Sci U S A (2005) 2.08
Comparative metagenomics and population dynamics of the gut microbiota in mother and infant. Genome Biol Evol (2010) 2.00
A metagenomic approach to characterization of the vaginal microbiome signature in pregnancy. PLoS One (2012) 1.98
A special fondness for lactobacilli. Appl Environ Microbiol (2004) 1.97
WholePathwayScope: a comprehensive pathway-based analysis tool for high-throughput data. BMC Bioinformatics (2006) 1.95
Bacterial sensor Nod2 prevents inflammation of the small intestine by restricting the expansion of the commensal Bacteroides vulgatus. Immunity (2014) 1.94
Immune responses that adapt the intestinal mucosa to commensal intestinal bacteria. Immunology (2005) 1.89
Commensal bacteria modulate cullin-dependent signaling via generation of reactive oxygen species. EMBO J (2007) 1.86
Bacterial interactions with cells of the intestinal mucosa: Toll-like receptors and NOD2. Gut (2005) 1.84
Quantification of uncultured Ruminococcus obeum-like bacteria in human fecal samples by fluorescent in situ hybridization and flow cytometry using 16S rRNA-targeted probes. Appl Environ Microbiol (2002) 1.82
Transcriptional patterns in both host and bacterium underlie a daily rhythm of anatomical and metabolic change in a beneficial symbiosis. Proc Natl Acad Sci U S A (2010) 1.82
Colonic microbiome is altered in alcoholism. Am J Physiol Gastrointest Liver Physiol (2012) 1.79
The bacterial fermentation product butyrate influences epithelial signaling via reactive oxygen species-mediated changes in cullin-1 neddylation. J Immunol (2009) 1.78
Genetic diversity of viable, injured, and dead fecal bacteria assessed by fluorescence-activated cell sorting and 16S rRNA gene analysis. Appl Environ Microbiol (2005) 1.74
Impaired carbohydrate digestion and transport and mucosal dysbiosis in the intestines of children with autism and gastrointestinal disturbances. PLoS One (2011) 1.74
Role of the gut microbiota in defining human health. Expert Rev Anti Infect Ther (2010) 1.73
Host-bacterial symbiosis in health and disease. Adv Immunol (2010) 1.73
Toll-like receptor 5 engagement modulates tumor development and growth in a mouse xenograft model of human colon cancer. Gastroenterology (2008) 1.70
Copper in microbial pathogenesis: meddling with the metal. Cell Host Microbe (2012) 1.69
The gut microbiome, kidney disease, and targeted interventions. J Am Soc Nephrol (2013) 1.67
The Bifidobacterium dentium Bd1 genome sequence reflects its genetic adaptation to the human oral cavity. PLoS Genet (2009) 1.64
Specific probiotic therapy attenuates antibiotic induced visceral hypersensitivity in mice. Gut (2005) 1.63
Microbial contact during pregnancy, intestinal colonization and human disease. Nat Rev Gastroenterol Hepatol (2012) 1.62
Toll-like receptors in tumor immunotherapy. Clin Cancer Res (2007) 1.60
Sorting mouse jejunal epithelial cells with CD24 yields a population with characteristics of intestinal stem cells. Am J Physiol Gastrointest Liver Physiol (2010) 1.60
Influence of microbial environment on autoimmunity. Nat Immunol (2009) 1.59
Brain-gut-microbe communication in health and disease. Front Physiol (2011) 1.59
Immune response of Anopheles gambiae to the early sporogonic stages of the human malaria parasite Plasmodium falciparum. EMBO J (2002) 1.59
Modulation of immune homeostasis by commensal bacteria. Curr Opin Microbiol (2011) 1.57
Innate immune recognition of the microbiota promotes host-microbial symbiosis. Nat Immunol (2013) 1.53
A general O-glycosylation system important to the physiology of a major human intestinal symbiont. Cell (2009) 1.53
Exploring host-microbiota interactions in animal models and humans. Genes Dev (2013) 1.51
Comparative analysis of Korean human gut microbiota by barcoded pyrosequencing. PLoS One (2011) 1.49
Intestinal microbiota regulate xenobiotic metabolism in the liver. PLoS One (2009) 1.49
Cd1d-dependent regulation of bacterial colonization in the intestine of mice. J Clin Invest (2009) 1.49
Visualization of mucosal homeostasis via single- and multiphoton intravital fluorescence microscopy. J Leukoc Biol (2012) 1.47
Robustness trade-offs and host-microbial symbiosis in the immune system. Mol Syst Biol (2006) 1.46
Colitis-associated variant of TLR2 causes impaired mucosal repair because of TFF3 deficiency. Gastroenterology (2009) 1.46
Probiotics: a role in the treatment of intestinal infection and inflammation? Gut (2002) 1.46
Reciprocal interactions between commensal bacteria and gamma delta intraepithelial lymphocytes during mucosal injury. J Immunol (2009) 1.46
Lactobacillus rhamnosus blocks inflammatory signaling in vivo via reactive oxygen species generation. Free Radic Biol Med (2009) 1.45
Spatial distribution and stability of the eight microbial species of the altered schaedler flora in the mouse gastrointestinal tract. Appl Environ Microbiol (2004) 1.45
Delivery of a mucin domain enriched in cysteine residues strengthens the intestinal mucous barrier. Sci Rep (2015) 1.45
Regional mucosa-associated microbiota determine physiological expression of TLR2 and TLR4 in murine colon. PLoS One (2010) 1.45
The microenvironment of injured murine gut elicits a local pro-restitutive microbiota. Nat Microbiol (2016) 1.44
Gingival epithelial cell transcriptional responses to commensal and opportunistic oral microbial species. Infect Immun (2007) 1.44
Effect of Lactobacillus gasseri BNR17 on Overweight and Obese Adults: A Randomized, Double-Blind Clinical Trial. Korean J Fam Med (2013) 1.43
Prebiotic carbohydrates modify the mucosa associated microflora of the human large bowel. Gut (2004) 1.41
The oral microbial consortium's interaction with the periodontal innate defense system. DNA Cell Biol (2009) 1.41
Pea fiber and wheat bran fiber show distinct metabolic profiles in rats as investigated by a 1H NMR-based metabolomic approach. PLoS One (2014) 1.41
An Intestinal Organ Culture System Uncovers a Role for the Nervous System in Microbe-Immune Crosstalk. Cell (2017) 1.39
Probiotic bacteria induce maturation of intestinal claudin 3 expression and barrier function. Am J Pathol (2011) 1.38
Probiotic Lactobacillus spp. diminish Helicobacter hepaticus-induced inflammatory bowel disease in interleukin-10-deficient mice. Infect Immun (2005) 1.37
Layers of mutualism with commensal bacteria protect us from intestinal inflammation. Gut (2006) 1.36
Commensal host-bacterial relationships in the gut. Science (2001) 14.82
Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension) Lancet (1991) 9.57
Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature (1995) 8.53
The biology and enzymology of eukaryotic protein acylation. Annu Rev Biochem (1988) 6.83
A model of host-microbial interactions in an open mammalian ecosystem. Science (1996) 5.85
Tissue-specific expression, developmental regulation, and genetic mapping of the gene encoding CCAAT/enhancer binding protein. Genes Dev (1989) 5.51
Coronary heart-disease after treatment of hypertension. Lancet (1978) 3.78
A molecular sensor that allows a gut commensal to control its nutrient foundation in a competitive ecosystem. Proc Natl Acad Sci U S A (1999) 3.63
Phenotype of mice lacking functional Deleted in colorectal cancer (Dcc) gene. Nature (1997) 3.57
Mutation frequency and biological cost of antibiotic resistance in Helicobacter pylori. Proc Natl Acad Sci U S A (2001) 3.42
Examining the role of Paneth cells in the small intestine by lineage ablation in transgenic mice. J Biol Chem (1997) 3.42
Molecular mechanics of calcium-myristoyl switches. Nature (1997) 3.36
Treatment of severe refractory autoimmune hemolytic anemia in B-cell chronic lymphocytic leukemia with alemtuzumab (humanized CD52 monoclonal antibody). Leukemia (2007) 3.33
Inflammatory bowel disease and adenomas in mice expressing a dominant negative N-cadherin. Science (1995) 3.16
Primary activation of the vitellogenin gene in the rooster. J Biol Chem (1977) 3.14
The biology and enzymology of protein N-myristoylation. J Biol Chem (2001) 3.14
Creating and maintaining the gastrointestinal ecosystem: what we know and need to know from gnotobiology. Microbiol Mol Biol Rev (1998) 3.09
Epithelial attachment alters the outcome of Helicobacter pylori infection. Proc Natl Acad Sci U S A (1998) 2.96
In vivo analysis of cadherin function in the mouse intestinal epithelium: essential roles in adhesion, maintenance of differentiation, and regulation of programmed cell death. J Cell Biol (1995) 2.95
Effects of clonidine withdrawal: possible mechanisms and suggestions for management. Br Med J (1973) 2.87
The Min (multiple intestinal neoplasia) mutation: its effect on gut epithelial cell differentiation and interaction with a modifier system. J Cell Biol (1992) 2.76
1999 World Health Organization-International Society of Hypertension Guidelines for the management of hypertension. Guidelines sub-committee of the World Health Organization. Clin Exp Hypertens (1999) 2.72
Protein N-myristoylation in Escherichia coli: reconstitution of a eukaryotic protein modification in bacteria. Proc Natl Acad Sci U S A (1990) 2.61
An in vitro adherence assay reveals that Helicobacter pylori exhibits cell lineage-specific tropism in the human gastric epithelium. Proc Natl Acad Sci U S A (1993) 2.44
Enhanced gluconeogenesis and increased energy storage as hallmarks of aging in Saccharomyces cerevisiae. J Biol Chem (2001) 2.39
Tumour markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines for clinical use. Eur J Cancer (2007) 2.36
Effects of forced expression of an NH2-terminal truncated beta-Catenin on mouse intestinal epithelial homeostasis. J Cell Biol (1998) 2.36
Purification and characterization of yeast myristoyl CoA:protein N-myristoyltransferase. Proc Natl Acad Sci U S A (1987) 2.36
Crystal structure of rat intestinal fatty-acid-binding protein. Refinement and analysis of the Escherichia coli-derived protein with bound palmitate. J Mol Biol (1989) 2.32
Hypertension is related to cognitive impairment: a 20-year follow-up of 999 men. Hypertension (1998) 2.31
Genetic and biochemical studies of protein N-myristoylation. Annu Rev Biochem (1994) 2.30
Inducible gene knockouts in the small intestinal and colonic epithelium. J Biol Chem (1999) 2.28
Genetic mosaic analysis based on Cre recombinase and navigated laser capture microdissection. Proc Natl Acad Sci U S A (2000) 2.26
Myristoyl CoA:protein N-myristoyltransferase activities from rat liver and yeast possess overlapping yet distinct peptide substrate specificities. J Biol Chem (1988) 2.17
Blood pressure crisis following withdrawal of clonidine (Catapres, Catapresan), with special reference to arterial and urinary catecholamine levels, and suggestions for acute management. Am Heart J (1973) 2.17
Paneth cell differentiation in the developing intestine of normal and transgenic mice. Proc Natl Acad Sci U S A (1994) 2.16
Home blood pressure determination. Value in borderline ("labile") hypertension. JAMA (1974) 2.16
G-protein alpha-subunit expression, myristoylation, and membrane association in COS cells. Proc Natl Acad Sci U S A (1990) 2.13
The human and rodent intestinal fatty acid binding protein genes. A comparative analysis of their structure, expression, and linkage relationships. J Biol Chem (1987) 2.13
Transgenic mice containing intestinal fatty acid-binding protein-human growth hormone fusion genes exhibit correct regional and cell-specific expression of the reporter gene in their small intestine. Proc Natl Acad Sci U S A (1988) 2.12
Initial clinical experience with I.C.I. 66.082, a new beta-adrenergic blocking agent, in hypertension. Acta Med Scand (1973) 2.10
The 1993 guidelines for the management of mild hypertension: memorandum from a WHO/ISH meeting. Blood Press (1993) 2.03
Mechanisms underlying generation of gradients in gene expression within the intestine: an analysis using transgenic mice containing fatty acid binding protein-human growth hormone fusion genes. Genes Dev (1988) 2.01
Coordinate regulation of two estrogen-dependent genes in avian liver. Proc Natl Acad Sci U S A (1980) 2.00
Comparison of genetic divergence and fitness between two subclones of Helicobacter pylori. Infect Immun (2001) 1.98
Mapping enteroendocrine cell populations in transgenic mice reveals an unexpected degree of complexity in cellular differentiation within the gastrointestinal tract. J Cell Biol (1990) 1.94
Renal function and intensive lowering of blood pressure in hypertensive participants of the hypertension optimal treatment (HOT) study. J Am Soc Nephrol (2001) 1.94
Operon prediction without a training set. Bioinformatics (2004) 1.94
The tissue-specific expression and developmental regulation of two nuclear genes encoding rat mitochondrial proteins. Medium chain acyl-CoA dehydrogenase and mitochondrial malate dehydrogenase. J Biol Chem (1989) 1.91
The fatty liver dystrophy (fld) mutation. A new mutant mouse with a developmental abnormality in triglyceride metabolism and associated tissue-specific defects in lipoprotein lipase and hepatic lipase activities. J Biol Chem (1989) 1.91
Transgenic mouse models that explore the multistep hypothesis of intestinal neoplasia. J Cell Biol (1993) 1.91
Clinical utility of biochemical markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines. Eur J Cancer (2003) 1.86
Disruption of the yeast N-myristoyl transferase gene causes recessive lethality. Science (1989) 1.83
Notes from some crypt watchers: regulation of renewal in the mouse intestinal epithelium. Curr Opin Cell Biol (1998) 1.83
Forced expression of E-cadherin in the mouse intestinal epithelium slows cell migration and provides evidence for nonautonomous regulation of cell fate in a self-renewing system. Genes Dev (1996) 1.82
DNA microarrays and beyond: completing the journey from tissue to cell. Nat Cell Biol (2001) 1.80
Forced expression of the tumor suppressor adenomatosis polyposis coli protein induces disordered cell migration in the intestinal epithelium. Proc Natl Acad Sci U S A (1996) 1.80
Diphtheria toxin-mediated ablation of parietal cells in the stomach of transgenic mice. J Biol Chem (1996) 1.78
Sip2p and its partner snf1p kinase affect aging in S. cerevisiae. Genes Dev (2000) 1.77
Expression of a human alpha-1,3/4-fucosyltransferase in the pit cell lineage of FVB/N mouse stomach results in production of Leb-containing glycoconjugates: a potential transgenic mouse model for studying Helicobacter pylori infection. Proc Natl Acad Sci U S A (1995) 1.77
Passage through stationary phase advances replicative aging in Saccharomyces cerevisiae. Proc Natl Acad Sci U S A (1999) 1.76
Inhibition of influenza virus infections in mice by GS4104, an orally effective influenza virus neuraminidase inhibitor. Antiviral Res (1998) 1.75
Reversal of left ventricular hypertrophy in hypertensive patients. A metaanalysis of 109 treatment studies. Am J Hypertens (1992) 1.73
Targeted gene replacement demonstrates that myristoyl-CoA: protein N-myristoyltransferase is essential for viability of Cryptococcus neoformans. Proc Natl Acad Sci U S A (1994) 1.72
Glycans as legislators of host-microbial interactions: spanning the spectrum from symbiosis to pathogenicity. Glycobiology (2001) 1.71
Lipid modifications of G protein subunits. Myristoylation of Go alpha increases its affinity for beta gamma. J Biol Chem (1991) 1.70
Regulation of creatine phosphokinase expression during differentiation of BC3H1 cells. J Biol Chem (1983) 1.70
The Hypertension Optimal Treatment (HOT) Study--patient characteristics: randomization, risk profiles, and early blood pressure results. Blood Press (1994) 1.70
The primary translation product of rat intestinal apolipoprotein A-I mRNA is an unusual preproprotein. J Biol Chem (1982) 1.69
Lectins are sensitive tools for defining the differentiation programs of mouse gut epithelial cell lineages. Am J Physiol (1994) 1.67
Expression and transport properties of the human ileal and renal sodium-dependent bile acid transporter. Am J Physiol (1998) 1.63
The metabolic significance of mammalian fatty-acid-binding proteins: abundant proteins in search of a function. Annu Rev Nutr (1987) 1.63
[There is no reason to avoid calcium antagonists in hypertension]. Lakartidningen (1996) 1.62
Expression of rat apolipoprotein A-IV and A-I genes: mRNA induction during development and in response to glucocorticoids and insulin. Proc Natl Acad Sci U S A (1985) 1.61
Expression of rat intestinal fatty acid-binding protein in Escherichia coli. Purification and comparison of ligand binding characteristics with that of Escherichia coli-derived rat liver fatty acid-binding protein. J Biol Chem (1987) 1.58
Impaired prostate tumorigenesis in Egr1-deficient mice. Nat Med (2001) 1.55
A new approach for filtering noise from high-density oligonucleotide microarray datasets. Nucleic Acids Res (2001) 1.54
Refinement of the structure of recombinant rat intestinal fatty acid-binding apoprotein at 1.2-A resolution. J Biol Chem (1992) 1.54
Initial clinical experience with ICI 141,292 (Visacor), a new selective beta 1-adrenoceptor blocker with ISA--a multicentre trial in 59 patients. Br J Clin Pharmacol (1984) 1.53
A transgenic mouse model of metastatic prostate cancer originating from neuroendocrine cells. Proc Natl Acad Sci U S A (1998) 1.53
Relation between drug treatment and cancer in hypertensives in the Swedish Trial in Old Patients with Hypertension 2: a 5-year, prospective, randomised, controlled trial. Lancet (2001) 1.52
Cloning and molecular characterization of the ontogeny of a rat ileal sodium-dependent bile acid transporter. J Clin Invest (1995) 1.52
Helicobacter pylori attaches to NeuAc alpha 2,3Gal beta 1,4 glycoconjugates produced in the stomach of transgenic mice lacking parietal cells. Mol Cell (1999) 1.51
Understanding covalent modifications of proteins by lipids: where cell biology and biophysics mingle. Trends Cell Biol (1997) 1.51
Cloning of a double-stranded cDNA that codes for a portion of chicken preproalbumin. A general method for isolating a specific DNA sequence from partially purified mRNA. J Biol Chem (1978) 1.50
Effects of cidofovir on the pathogenesis of a lethal vaccinia virus respiratory infection in mice. Antiviral Res (2001) 1.50
Aluminium and fluoride concentrations of three tea varieties growing at Lantau Island, Hong Kong. Environ Geochem Health (2003) 1.50
Capsaicin-induced cough in humans. Am Rev Respir Dis (1992) 1.49